255 related articles for article (PubMed ID: 15295921)
1. Incontinentia pigmenti: a window to the role of NF-kappaB function.
Bruckner AL
Semin Cutan Med Surg; 2004 Jun; 23(2):116-24. PubMed ID: 15295921
[TBL] [Abstract][Full Text] [Related]
2. [Proposal for a protocol for the staging of incontinentia pigmenti in pediatric age].
Portaleone D; Taroni F; Micheli S; Moioli M; Pedrazzini A; Cognizzoli P; Carnelli V
Minerva Pediatr; 2007 Jun; 59(3):255-65. PubMed ID: 17519871
[TBL] [Abstract][Full Text] [Related]
3. Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology.
Berlin AL; Paller AS; Chan LS
J Am Acad Dermatol; 2002 Aug; 47(2):169-87; quiz 188-90. PubMed ID: 12140463
[TBL] [Abstract][Full Text] [Related]
4. Incontinentia pigmenti: treatment of IP with topical tacrolimus.
Jessup CJ; Morgan SC; Cohen LM; Viders DE
J Drugs Dermatol; 2009 Oct; 8(10):944-6. PubMed ID: 19852125
[TBL] [Abstract][Full Text] [Related]
5. Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.
Nenci A; Huth M; Funteh A; Schmidt-Supprian M; Bloch W; Metzger D; Chambon P; Rajewsky K; Krieg T; Haase I; Pasparakis M
Hum Mol Genet; 2006 Feb; 15(4):531-42. PubMed ID: 16399796
[TBL] [Abstract][Full Text] [Related]
6. NF-kappa B defects in humans: the NEMO/incontinentia pigmenti connection.
Courtois G; Israël A
Sci STKE; 2000 Nov; 2000(58):pe1. PubMed ID: 11752619
[TBL] [Abstract][Full Text] [Related]
7. Incontinentia pigmenti.
Motamedi MH; Lotfi A; Azizi T; Moshref M; Farhadi S
Indian J Pathol Microbiol; 2010; 53(2):302-4. PubMed ID: 20551538
[TBL] [Abstract][Full Text] [Related]
8. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes.
Smahi A; Courtois G; Rabia SH; Döffinger R; Bodemer C; Munnich A; Casanova JL; Israël A
Hum Mol Genet; 2002 Oct; 11(20):2371-5. PubMed ID: 12351572
[TBL] [Abstract][Full Text] [Related]
9. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
[TBL] [Abstract][Full Text] [Related]
10. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
[TBL] [Abstract][Full Text] [Related]
11. Incontinentia pigmenti in male patients.
Pacheco TR; Levy M; Collyer JC; de Parra NP; Parra CA; Garay M; Aprea G; Moreno S; Mancini AJ; Paller AS
J Am Acad Dermatol; 2006 Aug; 55(2):251-5. PubMed ID: 16844507
[TBL] [Abstract][Full Text] [Related]
12. Clinical and molecular analysis of NF-kappaB essential modulator in Chinese incontinentia pigmenti patients.
Zou CC; Zhao ZY
Int J Dermatol; 2007 Oct; 46(10):1017-22. PubMed ID: 17910706
[TBL] [Abstract][Full Text] [Related]
13. Incontinentia pigmenti and hypomelanosis of Ito.
Bodemer C
Handb Clin Neurol; 2013; 111():341-7. PubMed ID: 23622185
[TBL] [Abstract][Full Text] [Related]
14. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder.
Ehrenreich M; Tarlow MM; Godlewska-Janusz E; Schwartz RA
Cutis; 2007 May; 79(5):355-62. PubMed ID: 17569396
[TBL] [Abstract][Full Text] [Related]
15. De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant: a case report.
Culić V; Gabrić D; Puizina-Ivić N; Rozman K; Peterlin B; Pavelić J
Coll Antropol; 2008 Dec; 32(4):1259-62. PubMed ID: 19149237
[TBL] [Abstract][Full Text] [Related]
16. Incontinentia pigmenti with a foreshortened hand: evidence for the significance of NFkappaB in human morphogenesis.
Kmetz EC; Shashidhar Pai G; Burges GE
Pediatr Dermatol; 2009; 26(1):83-6. PubMed ID: 19250414
[TBL] [Abstract][Full Text] [Related]
17. [Two neonates with vesicular skin lesions due to incontinentia pigmenti].
Winterberg DH; van Tijn DA; Smitt JH; Winterberg S; Vomberg PP
Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2178-82. PubMed ID: 11727618
[TBL] [Abstract][Full Text] [Related]
18. Incontinentia pigmenti (Bloch-Sulzberger syndrome).
Narayanan MJ; Rangasamy S; Narayanan V
Handb Clin Neurol; 2015; 132():271-80. PubMed ID: 26564087
[TBL] [Abstract][Full Text] [Related]
19. Incontinentia pigmenti with ultrastructurally disordered leucocytes.
Minić S; Trpinac D; Obradović M; Novotny GE; Gabriel HD; Kuhn M
J Clin Pathol; 2010 Jul; 63(7):657-9. PubMed ID: 20591917
[TBL] [Abstract][Full Text] [Related]
20. NEMO, NFkappaB signaling and incontinentia pigmenti.
Nelson DL
Curr Opin Genet Dev; 2006 Jun; 16(3):282-8. PubMed ID: 16647846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
